Cancers, Vol. 16, Pages 1624: Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma

Conclusions: The short-term LEN-TACE is feasible and safe, demonstrating promising outcomes with a high CR ratio, contributing to lipiodol retention in the tumor after cTACE, and extended PFS. To confirm the advantages of this treatment protocol, a prospective clinical trial is mandatory.

Source: Cancers - April 23, 2024 Category: Cancer & Oncology Authors: Tetsuya Tachiiri Kiyoyuki Minamiguchi Ryosuke Taiji Takeshi Sato Shohei Toyoda Takeshi Matsumoto Yuto Chanoki Hideki Kunichika Satoshi Yamauchi Sho Shimizu Hideyuki Nishiofuku Nagaaki Marugami Yuki Tsuji Tadashi Namisaki Hitoshi Yoshiji Toshihiro Tanaka Tags: Article Source Type: research